Newsroom

Sorted by: Latest
-

A Premier Jumping League (PJL) és a McCarthy Jumping Team mérföldkőnek számító beszerzést jelent be

NEW YORK--(BUSINESS WIRE)--A Premier Jumping League (PJL) a mai napon bejelentette, hogy a tapasztalt kereskedő, befektető és autóversenyző, Jason McCarthy és a McCarthy Jumping League LLC egy mérföldkőnek számító 50 millió dolláros akvizíció keretében felvásárolta az első PJL csapatot, és ezzel tovább épít a hatalmas elismerésnek örvendő profi díjugrató liga növekvő lendületére. A mérföldkőnek számító befektetés példátlan értékelést jelent egy újonnan alapított sportversenyben szereplő csapat...
-

La Premier Jumping League (PJL) y McCarthy Jumping Team anuncian una adquisición histórica

NUEVA YORK--(BUSINESS WIRE)--La Premier Jumping League (PJL) anunció hoy que el experimentado operador bursátil, inversionista y piloto de automovilismo de competición Jason McCarthy y McCarthy Jumping League LLC adquirieron el primer equipo de la PJL en una operación histórica valuada en 50 millones de dólares, lo que consolida el impulso que ha venido cobrando esta aclamada liga profesional de salto ecuestre. Esta inversión histórica representa una valoración sin precedentes para un equipo de...
-

A Premier Jumping League (PJL) e a McCarthy Jumping Team anunciam aquisição histórica

NOVA YORK--(BUSINESS WIRE)--A Premier Jumping League (PJL) anunciou hoje que o experiente corretor, investidor e piloto de corridas Jason McCarthy e a McCarthy Jumping League LLC adquiriram a primeira equipe da PJL em uma aquisição histórica de US$ 50 milhões, aproveitando o impulso crescente da aclamada liga profissional de salto a cavalo. Esse investimento marcante representa uma avaliação sem precedentes para uma equipe em uma competição esportiva recém-criada e ressalta a confiança que inve...
-

HAFNIA LIMITED: Hafnia Announces Planned CEO Succession

SINGAPORE--(BUSINESS WIRE)--Hafnia Limited (“Hafnia”, the “Company”, OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”) announces today that Mikael Skov has decided to step down as Chief Executive Officer (CEO) of Hafnia effective 1 September 2026. The Board of Directors has appointed Søren Steenberg Jensen, EVP, Head of Asset Management to succeed Mikael as CEO. Mikael Skov has led Hafnia since its establishment in 2010 and has played a defining role in building the Company into one of the wo...
-

In Line With the LEAP | 28 Portfolio Rotation Strategy, Bureau Veritas Signs an Agreement to Sell Its Oil & Petrochemicals and Coal Testing and Inspection Business

COURBEVOIE, France--(BUSINESS WIRE)--Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), announces that it has entered exclusive negotiations with Triton Partners regarding the sale of its Oil & Petrochemicals and Coal testing and inspection business. This strategic divestment is in full alignment with the Group’s LEAP | 28 strategy. The proposed transaction would include the Oil & Petrochemicals and Coal testing and inspection activities. In 2025,...
-

Conformément à sa stratégie de rotation du portefeuille LEAP | 28, Bureau Veritas signe un accord en vue de céder ses activités d’essais et d’inspection de Produits Pétroliers & Pétrochimiques et Charbon

COURBEVOIE, France--(BUSINESS WIRE)--Bureau Veritas, un leader mondial des services de Test, Inspection et Certification (TIC), annonce être entré en négociations exclusives avec Triton Partners en vue de la cession de ses activités d’essais et d’inspection de Produits Pétroliers & Pétrochimiques et Charbon. Cette cession stratégique s’inscrit pleinement dans la stratégie LEAP | 28 du Groupe. La transaction envisagée porterait sur les activités d’essais et d’inspection de Produits Pétrolier...
-

Corient accélère sa croissance européenne avec l’acquisition de Letus Private Office

MIAMI et PARIS--(BUSINESS WIRE)--Corient a annoncé aujourd’hui un accord portant sur l’acquisition de Letus Private Office (« Letus »), un multi-family office indépendant et cabinet de conseil en gestion de fortune au service d’entrepreneurs et de familles fortunées en France et en Europe. L’acquisition, sujette à finalisation, capitalise sur les transactions récentes qui ont fait de Corient le plus grand multi-family office et gestionnaire de fortune non bancaire au monde, focalisé sur la clie...
-

Corient Accelerates European Growth With the Addition of Letus Private Office

MIAMI & PARIS--(BUSINESS WIRE)--Corient acquires Letus Private Office, a wealth advisory firm serving ultra-high-net-worth individuals and families across France and Europe....
-

FDA Grants Priority Review To Genentech’s Application for Enspryng, the First and Only At-Home Subcutaneous Treatment Option for Thyroid Eye Disease (TED)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental Biologics License Application (sBLA) for Enspryng® (satralizumab) for the treatment of thyroid eye disease (TED). The filing acceptance is based on results from the two randomized, placebo-controlled global Phase III SatraGO studies assessing the safety and ef...
-

Hengrui’s Heng Yi® Approved in China as an Innovative Cyclosporine Ophthalmic Solution for the Treatment of Dry Eye Disease

SHANGHAI & HEIDELBERG, Germany & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Hengrui Pharma, a global pharmaceutical company focused on scientific and technological innovation, and Novaliq GmbH (“Novaliq”), a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique EyeSol® water-free platform technology, announce today that on June 23, 2026, the China National Medical Products Administration (NMPA) has approved Heng Yi® (0.1% cyclosporine ophthalmic solution...